Valuation GKB Ophthalmics Limited
Stocks
GKB
INE265D01015
Medical Equipment, Supplies & Distribution
|
Delayed
Bombay S.E.
01:53:41 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 61.99 INR | -2.65% |
|
+0.91% | +20.98% |
Company Valuation: GKB Ophthalmics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 413.3 | 463.7 | 547.2 | 439.6 | 304.1 | 264.6 |
| Change | - | 12.2% | 17.99% | -19.65% | -30.82% | -12.99% |
| Enterprise Value (EV) 1 | 363.7 | 423.1 | 518.2 | 382.4 | 319.7 | 337 |
| Change | - | 16.34% | 22.46% | -26.2% | -16.39% | 5.4% |
| P/E | -45.5x | 36.4x | -327x | -15.6x | -4.32x | 21.7x |
| PBR | 0.66x | 0.73x | 0.87x | 0.74x | 0.58x | 0.5x |
| PEG | - | -0x | 3x | -0x | -0x | -0x |
| Capitalization / Revenue | 0.73x | 0.65x | 0.72x | 0.5x | 0.28x | 0.18x |
| EV / Revenue | 0.64x | 0.6x | 0.69x | 0.43x | 0.29x | 0.23x |
| EV / EBITDA | 15.3x | 8.55x | 14.1x | 66.2x | -10.9x | 3.93x |
| EV / EBIT | -48.1x | 18.5x | 60.5x | -16.5x | -5.3x | 6.28x |
| EV / FCF | -38.7x | -25.6x | -8.45x | 15.9x | -6.64x | -13.3x |
| FCF Yield | -2.58% | -3.9% | -11.8% | 6.28% | -15.1% | -7.51% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.8 | 2.528 | -0.3321 | -5.58 | -13.98 | 2.417 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 568.8 | 709.4 | 754.7 | 882.5 | 1,090 | 1,491 |
| EBITDA 1 | 23.83 | 49.52 | 36.83 | 5.779 | -29.45 | 85.77 |
| EBIT 1 | -7.568 | 22.85 | 8.561 | -23.2 | -60.31 | 53.68 |
| Net income 1 | -9.075 | 12.74 | -1.674 | -28.1 | -70.45 | 12.18 |
| Net Debt 1 | -49.64 | -40.6 | -28.99 | -57.22 | 15.59 | 72.38 |
| Reference price 2 | 82.00 | 92.00 | 108.55 | 87.22 | 60.34 | 52.50 |
| Nbr of stocks (in thousands) | 5,041 | 5,041 | 5,041 | 5,041 | 5,041 | 5,041 |
| Announcement Date | 9/3/21 | 9/7/22 | 8/22/23 | 7/25/24 | 7/24/25 | 7/30/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 3.35M | |
| 28.84x | 2.8x | 11.32x | 2.5% | 87.21B | |
| 43.78x | 3.47x | 12.89x | 0.5% | 35.89B | |
| 37.19x | 3.93x | 12.6x | -.--% | 14.78B | |
| 122.31x | 9.28x | 44.74x | -.--% | 11.4B | |
| 25.07x | 6.23x | 17.7x | 1.12% | 2.51B | |
| 15.75x | 4.12x | 9.37x | 1.69% | 1.49B | |
| 21.03x | 1.44x | 8.32x | 1.48% | 918M | |
| 26.47x | 5.43x | 16.66x | 1.97% | 883M | |
| 13.73x | 2.81x | 7.22x | 3.12% | 869M | |
| Average | 37.13x | 4.39x | 15.65x | 1.37% | 15.6B | |
| Weighted average by Cap. | 39.57x | 3.61x | 14.32x | 1.58% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- GKB Stock
- Valuation GKB Ophthalmics Limited
Select your edition
All financial news and data tailored to specific country editions
